MedTrace Logo

Epidemiological Study on Community Acquired Pneumonia

NCT02139163 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2026-05-05

No results posted yet for this study

Summary

The main objective of this study is to investigate prevalence and risk factors for community-acquired pneumonia (CAP) and its interaction with comorbidities in an unselected group of adult patients receiving outpatient and inpatient care. In addition, information on HIV as a risk factor for CAP and on CAP in immunocompromised patients is collected.

Conditions

  • Community Acquired Pneumonia

Sponsors & Collaborators

  • Deutsches Zentrum für Lungenforschung e. V.

    collaborator UNKNOWN

  • Capnetz Stiftung

    lead OTHER

Principal Investigators

  • Gernot G. U. Rohde, Prof. Dr. · University Hospital Giessen and Marburg

  • Mathias W. R. Pletz, Prof. Dr. · University Hospital Jena

  • Jan Rupp, Prof. Dr. · University Hospital Schleswig-Holstein

  • Martin Witzenrath, Prof. Dr. · Charité - Universitaetsmedizin Berlin

  • Jessica Rademacher, Prof. Dr. · Medical School Hannover

  • Grit Barten-Neiner · Capnetz Stiftung

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2027-12-31
Completion
2028-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02139163 on ClinicalTrials.gov